Company intelligence / Profile preview

Shandong Wit Dyne Health

Jinan, Shandong, Chinasd-wit.com ↗

Ownership: Private
Employees: ~1760
Development stage: Commercial

Overview

Shandong Wit Dyne Health is a leading Chinese pharmaceutical company with a strong focus on pediatric medicines and children’s health products. The company has several commercialized products in China, including azithromycin granules, vitamin AD drops, glimepiride tablets, and others. It recently received clinical trial approval for a treatment targeting shortness of breath and obtained drug registration for an epilepsy treatment. The company is recognized as a high-tech enterprise with multiple national patents.

Therapeutic areas: EndocrinologyOtherCardiovascularNeurologyInfectious Diseases
Modalities: Small moleculeBiologic
Industry: Biotech

Drug pipeline

1 asset

Yiganxin

Unknown

Beyond the preview

Go deeper on Shandong Wit Dyne Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shandong Wit Dyne Health.

Explore the full profile